Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.
About this episode
Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.
(01:14)
Could you give us a brief overview of this assay?
(02:06)
Can you explain the differences of the qualitative and quantitative methods and why we made the change to a quantitative adenovirus method?
(04:00)
When is this test typically ordered for transplant patients? Is it used throughout their treatment?
(06:56)
Could an immunocompromised person be unknowingly infected?
(07:31)
Is our quantitative method approved for pediatric patients?
(08:00)
How are the test results used to treat patients?
(10:36)
What other infections might providers consider alongside adeovirus?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab